A Transversal Study for the French Validation of Two Assessment Tools of Gambling Related Cognitions.
Launched by NANTES UNIVERSITY HOSPITAL · Oct 12, 2010
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
This study is divided into two stages. In the first stage, students from the University of Nantes completed the two assessment tools of gambling related cognitions (GABS : Gambling Attitudes and Beliefs Survey ; GRCS : Gambling Related Cognitions Scale), and a reference tool for gambling problem severity (SOGS : South Oaks Gambling Screen).
In the second stage, consecutive pathological gamblers seeking treatment at the University Hospital of Nantes completed the three questionnaires.
Only questionnaires from participants who reported gambling at least one time in the past year were kept f...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • To be more than 18 years old (the legal age to gamble in France)
- Exclusion Criteria:
- • None
About Nantes University Hospital
Nantes University Hospital, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific exploration with patient care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Nantes University Hospital aims to contribute to the development of effective therapies and interventions that enhance patient outcomes and overall public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantes, , France
Patients applied
Trial Officials
Marie Grall-Bronnec, MD
Principal Investigator
Nantes University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials